Diagnostic Device Market to Reach USD 79.9 Billion by 2030 | Strong 6.9% CAGR | North America Leads with 35% Share | Key Players: GE Healthcare, Siemens Healthineers, Philips, Hologic

Diagnostic Device Market Overview

The Global Diagnostic Device Market reached USD 47 billion in 2022 and is projected to grow to USD 79.9 billion by 2030, exhibiting a CAGR of 6.9% during the forecast period 2024-2031. Diagnostic devices are critical in healthcare, enabling early detection, monitoring, and management of diseases and medical conditions. They provide accurate, timely, and actionable patient information, empowering healthcare professionals to make informed decisions on diagnosis, treatment, and care.

The market growth is fueled by the rising prevalence of chronic and infectious diseases, increasing demand for point-of-care testing, and technological innovations in diagnostic tools. Additionally, advancements in imaging, molecular diagnostics, and wearable diagnostic devices are driving adoption in hospitals, laboratories, and home healthcare settings.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/diagnostic-device-market?Juli

Recent Developments:

✅ November 2025: A leading medical technology company launched a next-generation point-of-care diagnostic platform that integrates AI-based image analysis with rapid molecular testing for infectious diseases.

✅ September 2025: A global diagnostics manufacturer expanded its portfolio of wearable diagnostic devices, enhancing remote patient monitoring capabilities for chronic disease management.

✅ July 2025: A major healthcare firm introduced an advanced multiplex PCR system capable of simultaneous detection of multiple pathogens, reducing test time and improving laboratory throughput.

✅ May 2025: A diagnostics innovator received regulatory approval for a novel liquid biopsy test that enables early-stage cancer detection using circulating tumor DNA.

✅ March 2025: Several diagnostic device companies launched integrated digital health platforms that link diagnostic results with electronic health records (EHRs) and telehealth systems, enhancing clinical decision support and care coordination.

Mergers & Acquisitions:

✅ October 2025: A leading U.S.-based diagnostic device company acquired a molecular diagnostics startup, enhancing its portfolio in rapid infectious disease testing and point-of-care solutions.

✅ August 2025: A global medical technology firm merged with a European imaging diagnostics company, expanding its footprint in advanced imaging systems and AI-assisted diagnostic tools.

✅ June 2025: A diagnostics conglomerate acquired a telehealth-integrated diagnostics platform provider, strengthening its remote patient monitoring and digital health capabilities.

✅ March 2025: A biotechnology company purchased a liquid biopsy and genomic diagnostics startup, accelerating innovation in early-stage cancer detection technologies.

Buy Now & Unlock 360° Market Intelligence:- https://www.datamintelligence.com/buy-now-page?report=diagnostic-device-market?Juli

Key Players:
GE Healthcare | Siemens Healthineers | Koninklijke Philips N.V | Canon Medical Systems Corporation | Carestream Health, Inc | Hologic, Inc | Allengers Medical Systems | SternMed | Neusoft Medical Systems | Medtronic Plc

Key Highlights:

GE Healthcare - Holds a 16.8% share, driven by advanced imaging systems, AI-integrated diagnostic platforms, and global service networks.

Siemens Healthineers - Holds a 15.5% share, supported by innovations in molecular diagnostics, laboratory automation, and AI-powered imaging solutions.

Koninklijke Philips N.V - Holds a 13.9% share, fueled by its portfolio of diagnostic imaging, ultrasound, and point-of-care testing systems.

Canon Medical Systems Corporation - Holds a 12.2% share, leveraging CT, MRI, and ultrasound solutions integrated with AI-assisted diagnostics.

Carestream Health, Inc - Holds a 9.8% share, focusing on digital radiography, imaging software, and enterprise diagnostic solutions.

Hologic, Inc - Holds a 7.6% share, driven by breast and skeletal health diagnostics, molecular testing, and minimally invasive diagnostic technologies.

Allengers Medical Systems - Holds a 5.4% share, supported by cost-effective imaging devices and diagnostic solutions in emerging markets.

SternMed - Holds a 4.1% share, focusing on laboratory diagnostic instruments and consumables.

Neusoft Medical Systems - Holds a 3.5% share, providing imaging systems and healthcare IT solutions in Asia-Pacific.

Medtronic Plc - Holds a 1.2% share, offering integrated diagnostic solutions in cardiovascular and minimally invasive surgical applications.

Market Segmentation:

➥ By Product Type, X-ray Imaging Systems lead with a 25% share, widely used for bone, chest, and dental diagnostics. Computed Tomography (CT) Scanners hold 20%, essential for detailed cross-sectional imaging in oncology, neurology, and trauma cases. Ultrasound Systems account for 18%, preferred for obstetrics, gynecology, and cardiology due to non-invasive imaging capabilities. Magnetic Resonance Imaging (MRI) Systems represent 15%, offering high-resolution imaging for soft tissue evaluation and neurological diagnostics. Nuclear Imaging Systems and Planar Scintigraphy Imaging Systems contribute 12% and 10%, respectively, providing functional imaging for cardiac, oncology, and metabolic studies.

➥ By Application, Oncology dominates with a 22% share, driven by rising cancer prevalence and demand for early detection. Cardiology holds 18%, supported by the increasing incidence of cardiovascular diseases and diagnostic imaging needs. Neurology accounts for 17%, fueled by the growing burden of neurodegenerative disorders. Orthopedic applications represent 15%, including fracture and musculoskeletal imaging. Obstetrics/Gynecology contributes 12%, Dental holds 9%, and Other applications such as gastroenterology and urology account for 7%.

➥ By End-User, Hospitals dominate with a 40% share, leveraging high-volume diagnostic imaging and advanced infrastructure. Diagnostic Laboratories hold 25%, focusing on specialized imaging and high-throughput workflows. Ambulatory Care Centers account for 15%, adopting portable and point-of-care diagnostic systems. Clinics represent 10%, offering cost-effective imaging for routine examinations. Other end-users contribute 10%, including research institutions, academic hospitals, and mobile imaging services.

Regional Insights:

North America leads the market with a 35% share, driven by advanced healthcare infrastructure, high adoption of diagnostic technologies, and strong healthcare expenditure in the U.S. and Canada. Increasing prevalence of chronic diseases and growing demand for early diagnosis further support market growth.

Europe holds a 28% share, fueled by well-established healthcare systems, government initiatives for advanced diagnostics, and increasing investments in imaging and molecular diagnostics. Countries like Germany, France, and the UK are key contributors.

Asia-Pacific (APAC) accounts for 25%, with growth supported by rapidly expanding healthcare infrastructure, rising awareness of early disease detection, and increasing medical tourism in China, Japan, India, and South Korea. Affordable diagnostics solutions are driving adoption in emerging economies.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/diagnostic-device-market?Juli

Market Dynamics:

Drivers - Rising Prevalence of Chronic Diseases and Aging Population
The global diagnostic device market is witnessing significant growth driven by the rising prevalence of chronic diseases and the rapidly growing geriatric population. The increasing burden of cardiovascular diseases (CVDs), diabetes, neurological disorders, and cancer is fueling demand for advanced diagnostic technologies.

According to the Centers for Disease Control and Prevention (CDC), nearly 80% of elderly individuals in the U.S. suffer from at least one chronic condition, while the American Medical Association (AMA) estimates that by 2030, around 60% of people aged 65 and above will live with more than one chronic disease. This growing aging population is creating an urgent need for early and accurate diagnostic solutions to manage and monitor complex health conditions effectively.

Additionally, technological advancements such as AI-driven imaging, portable diagnostic systems, and molecular diagnostic tools are enabling earlier detection, improved accuracy, and better treatment outcomes. The increasing integration of digital and point-of-care diagnostics into healthcare systems is also enhancing accessibility and efficiency.

Restraints - High Cost of Equipment and Procedures
Despite strong growth drivers, the high costs of diagnostic devices and related procedures remain a significant restraint on market expansion. Manufacturing, procurement, and maintenance of imaging systems such as MRI, CT, and PET scanners require substantial investment, which can strain healthcare budgets particularly in low- and middle-income regions.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.